The goal of this observational study is to evaluate the reliability of the Argos system to track changes in cardiac output in critically ill patients. The main question it aims to answer is:
Does cardiac output changes induced by fluid administration or changes in norepinephrine dosage can be tracked by the Argos system, compared to transpulmonary thermodilution device.
Inclusion Criteria:
Age ≥18 years old
Hospitalisation in intensive care
Haemodynamic monitoring with transpulmonary thermodilution already in place
Hemodynamic intervention deemed necessary by the clinician in charge of the patient
Exclusion Criteria:
christopher.lai@aphp.fr12633816521
Patients with shock defined by one sign of hypoperfusion: * systolic arterial pressure \<90mmHg * mean arterial pressure \<65mmHg * prolonged capillary refill time \>3 sec * mottling score \> 2 * urine output \< 0.1 mL/kg/h
Pharmacodynamic Analysis of the HaemOdynamic Effects of a Standard Fluid BolUS
O2 Consumption And CO2 Production After Hemodynamic Optimization In Shock
Value of Cardiac Output Monitoring by Supra-sternal Doppler/Echocardiography in Intensive Care Unit
Comparison of Allows Measurement of Cardiac Output Between Clearsight System and Transpulmonary Thermodilution
Norepinephrine vs Norepinephrine and Dobutamine in Cardiogenic Shock
The Clinical and Hemodynamic Course of Cardiogenic Shocks Hospitalized in Critical Care
Dynamic Estimation of Cardiac Output in the Operating Room
Computer Assisted Vasopressor Titration in Critically Ill Patients